Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. Shareholder Equity 2009–2025
Pacira BioSciences Inc. annual/quarterly shareholder equity history from 2010 to 2025. Shareholder equity represents the net worth of a company, calculated as total assets minus total liabilities.
- Pacira BioSciences Inc. shareholder equity for the quarter ending December 31, 2025 were 693.1M, a 10.95% decrease year-over-year.
- Pacira BioSciences Inc. shareholder equity for 2025 were 693.1M, a 10.95% decrease from 2024.
- Pacira BioSciences Inc. shareholder equity for 2024 were 778.3M, a 10.55% decrease from 2023.
- Pacira BioSciences Inc. shareholder equity for 2023 were 870.1M, a 12.27% increase from 2022.
- Pacira BioSciences Inc. shareholder equity for 2022 were 775.0M.
Shareholder Equity
QUARTERLY · $B
YOY QUARTERLY GROWTH · %
| Pacira BioSciences Inc. Annual Shareholder Equity (Millions of US $) | |
|---|---|
| 2025 | $693 |
| 2024 | $778 |
| 2023 | $870 |
| 2022 | $775 |
| 2021 | $730 |
| 2020 | $620 |
| 2019 | $355 |
| 2018 | $321 |
| 2017 | $279 |
| 2016 | $219 |
| 2015 | $218 |
| 2014 | $171 |
| 2013 | $41 |
| 2012 | $66 |
| 2011 | $48 |
| Pacira BioSciences Inc. Quarterly Shareholder Equity (Millions of US $) | |
|---|---|
| 2025-12-31 | $693 |
| 2024-12-31 | $778 |
| 2023-12-31 | $870 |
| 2022-12-31 | $775 |
| 2021-12-31 | $730 |
| 2020-12-31 | $620 |
| 2019-12-31 | $355 |
| 2018-12-31 | $321 |
| 2017-12-31 | $279 |
| 2016-12-31 | $219 |
| 2015-12-31 | $218 |
| 2014-12-31 | $171 |
| 2013-12-31 | $41 |
| 2012-12-31 | $66 |
| 2011-12-31 | $48 |
| 2010-12-31 | $-48 |
Pacira BioSciences Inc. Shareholder Equity — FAQ
Pacira BioSciences Inc. (PCRX) shareholder equity over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's shareholder equity history?
The chart and table above show Pacira BioSciences Inc.'s shareholder equity by year and by quarter, including the growth rate.